Panel orders centralized pretrial proceedings in NSF cases

March 20, 2008 Panel orders centralized pretrial proceedings in NSF cases Shalmali Pal -------------------------------------------------------------------------------- The discovery process for more than 60 federal lawsuits alleging a connection between cases of nephrogenic systemic fibrosis and gadolinium-based MR contrast agents will be consolidated at a single district court in Ohio, according to a U.S. judicial panel. Centralization will accelerate the discovery process and give plaintiffs access to a wider pool of pretrial information. As of late February, 66 federal cases had been filed on behalf of patients with renal failure who allege that gadolinium-based contrast agents triggered NSF, a life-threatening skin condition. In early March, a California couple filed a suit in the U.S. District Court for the Northern District of California against several contrast agent developers.

See full article and related articles at DiagnosticImaging.com
This article was republished with permission from CMPMedica, LLC